Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer

• Status: Completed
• Trial end date: 2021-01-05
• Target enrollment: 0
• Participant gender: All

Summary

The study is a randomized clinical trial that assesses the clinical success and the antibacterial effect on carious dentine of glass ionomer when modified with Chitosan and/or Titanium dioxide nano particles vs the control group of modification with Chlorhexidine as control when used in primary molars

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Chitosan; Chlorhexidine; Chlorhexidine gluconate; Titanium dioxide

Criteria

Inclusion Criteria:

The teeth will be primary molars selected from patients presented to the outpatient clinic that are

• Healthy patients.

• Age: 4-8 years.

• Children having at least one primary molar with only occlusal caries having dentine lesions wide enough for the smallest excavator to enter (Ø=0.9 mm).

Exclusion Criteria:

• Teeth with pulp involvement, those suffering from pain, irreversible pulpits or pulp necrosis.

• Children with systemic diseases.

• Patients with history of active para-functional oral habits, xerostomia.

• Patients who will have difficulties in cooperating.